FDA Modernization Act 2.0, NAMs, and Their Impact on Laboratories
Thanks to a new U.S. law, drugs under development no longer need to be tested on animals before being administered to volunteers in human trials. Long-time animal rights advocates have lobbied for this action, while some people working in the pharmaceutical sector have claimed that animal testing may be both expensive and ineffective. What effects will this have on laboratory operations moving forward? What is required in order to adapt to this change?
